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Background: The aims of this prospective population-based cohort study were to identify the 
patient and hospital characteristics associated with emergency cholecystectomy, and the 
influences of these in determining variations between hospitals. 
Methods: Data were collected for consecutive patients undergoing cholecystectomy in acute 
UK and Irish hospitals between 1 March and 1 May 2014. Potential explanatory variables 
influencing the performance of emergency cholecystectomy were analysed by means of 
multilevel, multivariable logistic regression modelling using a two-level hierarchical structure 
with patients (level 1) nested within hospitals (level 1).  
Results:  Data were collected on 4744 cholecystectomies from 165 hospitals. Increasing age, 
lower ASA fitness grade, biliary colic, the need for further imaging (magnetic retrograde 
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cholangiopancreatography), endoscopic interventions (endoscopic retrograde 
cholangiopancreatography) and admission to a non-biliary centre significantly reduced the 
likelihood of an emergency cholecystectomy being performed. The multilevel model was 
used to calculate the probability of receiving an emergency cholecystectomy for a woman 
aged 40 years or over with an ASA grade of I or II and a BMI of at least 25.0 kg/m2, who 
presented with acute cholecystitis with an ultrasound scan showing a thick-walled gallbladder 
and a normal common bile duct. The mean predicted probability of receiving an emergency 
cholecystectomy was 0.52 (95 per cent c.i. 0.45 to 0.57). The predicted probabilities ranged 
from 0.02 to 0.95 across the 165 hospitals, demonstrating significant variation between 
hospitals. 
Conclusion: Patients with similar characteristics presenting to different hospitals with acute 
gallbladder pathology do not receive comparable care.  
+A:  Introduction 
Benign gallbladder diseases are a major global health burden1,2. RCTs, meta-analyses and 
expert consensus support the use of emergency cholecystectomy for most patients presenting 
with biliary colic, acute cholecystitis or gallstone pancreatitis3–9. Compared with delayed 
cholecystectomy following discharge after an acute admission, emergency cholecystectomy 
is associated with less gallbladder-specific morbidity, a shorter total length of hospital stay 
and similar operative morbidity10–15. Despite this evidence, there is still thought to be wide 
variation in the management of patients presenting with acute gallbladder pathology. 
Reports from Europe, Asia and North America show rates of emergency 
cholecystectomy ranging from 12 to 88 per cent16–20. Within healthcare systems, patients with 
similar demographics and gallbladder pathologies also do not receive comparable care21. 
These variations may lead to avoidable morbidity, mortality and wasted resources22–24. 
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Patient and hospital factors are often cited to justify these wide differences in the use of 
emergency cholecystectomy. Understanding the specific patient and hospital characteristics 
that lead to these variations might address inconsistencies in care and improve outcomes.  
Over the past 8 years, trainee-led networks in the UK have adopted a collaborative 
approach to deliver population-level data collections using prospectively developed 
databases25. Using these networks, the aims of the present study were to identify patient and 
hospital characteristics associated with the use of cholecystectomy following acute admission 
with benign biliary disease, and to see how these factors influenced variations between 
hospitals in the use of emergency cholecystectomy. 
+A: Methods 
This prospective cohort population-based study was carried out as described previously26. 
The protocol did not require research registration as anonymized, observational data were 
collected. This was confirmed by the online National Research Ethics Service decision tool 
(http://www.hra-decisiontools.org.uk/research/), and further supported by written 
confirmation and advice from the Research and Development Director at University 
Hospitals Birmingham NHS Foundation Trust, UK.  The study was registered as a clinical 
audit or service evaluation at each participating hospital under the supervision of a named 
senior investigator (consultant surgeon). 
+B: Inclusion and exclusion criteria 
Consecutive patients undergoing cholecystectomy for benign gallbladder diseases, including 
those undergoing emergency surgery, in acute UK and Irish hospitals between 1 March and 1 
May 2014 were included, and data recorded using a prospectively developed database. This 
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study analysed patients who had emergency admissions with right upper quadrant pain and 
symptoms; therefore, all patients with ‘cholecystitis’ had acute cholecystitis.  
Patients were grouped according to the timing of cholecystectomy.  Emergency 
cholecystectomy was defined as a cholecystectomy during an acute admission; and delayed 
cholecystectomy was defined as a planned cholecystectomy following an emergency 
admission with gallbladder disease. Open, laparoscopic and laparoscopic converted to open 
operations were included. Patients who had a cholecystectomy for known gallbladder cancer 
or as a part of another surgical procedure, such as pancreaticoduodenectomy, bariatric, 
antireflux or transplant operations, were excluded.   
+B: Outcome measure 
The primary outcome of interest was the performance of emergency cholecystectomy in 
comparison with delayed surgery. 
+B: Data quality 
A quality assurance programme was developed26. This included a detailed study protocol, a 
pilot phase, and a requirement for a minimum of 95 per cent data completeness at 
submission. Case ascertainment and data accuracy were further validated by independent 
investigators at selected hospitals, who checked data accuracy in approximately 20 per cent 
of patients. These independent investigators were not involved in the original data collection. 
+B: Explanatory variables 
Patient, disease and hospital characteristics were considered as potential explanatory 
variables influencing the performance of emergency cholecystectomy. A full list including 
definitions has been published previously26. Briefly, patient characteristics included here 
were: age, sex, ASA fitness grade (I to V) and BMI (less than 17.9 kg/m2, underweight; 18.0–
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24.9 kg/m2, normal; 25.0–29.9 kg/m2, overweight; 30.0–34.9 kg/m2, moderate obesity; 35.0 
kg/m2 and above, severe or very severe obesity). The following disease characteristics were 
considered: indication (biliary colic, acute cholecystitis, pancreatitis, common bile duct 
(CBD) stones), ultrasound findings, including gallbladder wall thickness (considered thick-
walled if the wall was 2 mm or thicker) and a dilated CBD (CBD diameter 6 mm or greater), 
and other radiological investigations (CT, magnetic retrograde cholangiopancreatography 
(MRCP), endoscopic retrograde cholangiopancreatography (ERCP)).  
Hospital characteristics were determined by a participating centre questionnaire and 
included hospital type (non-university, university-affiliated), specialist hepatobiliary centre 
(no, yes), acute hospital (no, yes), number of consultants within the reporting hospital 
performing cholecystectomy, country, number of beds within the reporting hospital (less than 
100, 101–500, 501–1000, more than 1000) and the presence of an ERCP service. HPB 
centres were defined as hospitals offering tertiary HPB cancer resectional surgery as listed on 
the www.augis.org website. The hospital’s policy regarding the ease of performing 
intraoperative cholangiography, and availability and use of dedicated emergency gallbladder 
operating lists, were considered. Grade of senior surgeon performing cholecystectomy, 
consultant presence at surgery and the consultant specialty were also recorded. Hospital 
volume of cholecystectomies was determined by ranking hospitals in order of increasing 
volume and selecting cut-off points that sorted patients into three evenly sized cohorts with 
low, medium and high volume. 
+B: Statistical analysis 
Results are reported in accordance with the STROBE statement for observational studies27. 
Crude rates of emergency cholecystectomy for all patients at each hospital were calculated.  
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Descriptive statistics were obtained for all variables. The 2 test was used to identify 
differences between categorical variables. To enable exploration of between-hospital 
variation in the performance of emergency cholecystectomy, the data were analysed by 
means of multilevel, multivariable logistic regression modelling using a two-level 
hierarchical structure with patients at level 1, nested within hospitals at level 2. Initially a null 
two-level model was fitted, containing no explanatory variables, examining hospital-only 
effects. This model estimated the log-odds ratio (OR) of a patient receiving an emergency 
cholecystectomy at an ‘average’ hospital. The residual value was a measure of the variation 
at each hospital for a patient receiving an emergency cholecystectomy, calculated by 
subtracting the estimated log-OR for an average hospital from each hospital’s estimated log-
OR. The residual values were plotted in ascending order of magnitude with their respective 
95 per cent confidence intervals (c.i.).  
Explanatory variables were evaluated to determine whether any could explain the 
variation in performance of emergency cholecystectomy between hospitals, using a random 
intercept model. Univariable multilevel models were applied separately to each individual 
variable, investigating the significance of the variable as a whole and also the significance at 
each sublevel. No explanatory variables were excluded from the multivariable multilevel 
model building in order to allow for the presence of any confounders. Variable inclusion 
followed the forward and back Collett method for selection28. All two-way interactions were 
assessed to ensure that there were no significant interactions in the final model. Model testing 
was performed using likelihood ratio tests, Wald tests, residuals and deviance plots. When the 
multivariable random intercept model was finalized, the variance partition coefficient was 
calculated. This gives a measure of the amount of residual variation in the propensity of a 
patient to receive an emergency cholecystectomy that can be attributable to unobserved 
characteristics. 
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To further investigate the variations between hospitals, the random intercept model 
was extended to a random coefficient model, including each explanatory variable in turn, 
allowing the variable to vary across hospitals. Results are expressed as adjusted ORs with 95 
per cent confidence intervals.  
Finally, to provide a real-world interpretation of the data, the multilevel random 
intercept model was constructed using patient data whose true cholecystectomy surgery type 
(emergency or delayed) was known. Predicted probabilities were obtained using the model, 
based on patient characteristics for five common scenarios. The predicted probabilities 
obtained were grouped by patients known to have received either an emergency or delayed 
cholecystectomy. The mean predicted probabilities and corresponding 95 per cent confidence 
intervals were plotted. 
All statistical methods were performed using Stata® version 12 (StataCorp, College 
Station, Texas, USA). The multilevel, multivariable logistic regression modelling was carried 
out in MLwiN version 2.14 (http://www.cmm.bristol.ac.uk/MLwiN). 
+A:  Results 
Data were collected on 8914 patients undergoing cholecystectomy from 166 hospitals, using 
a prospectively developed database and agreed starting date, between 1 March 2014 and 1 
May 2014. Case ascertainment and accuracy of collected data were above 95.2 and 99.2 per 
cent respectively. Data from 23.3 per cent of all patients (2077 of 8914) were checked against 
the original medical records by independent data validators. This equated to 11.1 per cent of 
all data points (64 409 of 579 410). Within the entire data set, 0.8 per cent of data were 
missing. Of the 8914 patients, 4744 in 165 hospitals met the inclusion criteria. Data were 
complete for 4698 patients and 1451 (30.9 per cent) underwent emergency cholecystectomy.  
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Overall demographics according to whether surgery was carried out as an emergency 
or delayed are shown in Table 1. Patients undergoing emergency cholecystectomy were 
younger than those having delayed surgery: median (i.q.r.) age 50 (35–65) versus 54 (39–
67.0) years (P < 0.001). In addition, patients undergoing emergency cholecystectomy had 
higher ASA grades (P = 0.002), greater BMI (P = 0.034) and were more likely to have 
presented with acute cholecystitis or pancreatitis (P < 0.001).  
Considering hospital factors, 2142 (45.2 per cent) of all cholecystectomies were 
performed in university-affiliated hospitals and 1215 (25.6 per cent) in specialist HPB centres 
(Table 2). Emergency cholecystectomies were more likely to be performed in university 
hospitals (P < 0.001), specialist HPB centres (P < 0.001), hospitals with more beds (P < 
0.001), and hospitals that performed a higher volume of procedures during the study period 
(P < 0.001). Surgeons with a background in oesophagogastric or HPB surgery performed a 
greater proportion of the emergency operations than delayed operations (60.2 versus 56.3 per 
cent; P = 0.011). 
+B: Emergency cholecystectomy rates across hospitals 
There was marked variation in the rate of emergency cholecystectomy across hospitals 
(mean(s.d.) 26.4(23.3) per cent (range 0–100) per cent). This remained evident even when the 
analysis was limited to patients with acute cholecystitis, pancreatitis or biliary colic (Fig. 1).  
When the data were analysed by means of multilevel logistic regression modelling 
using a two-level hierarchical structure with 4698 patients at level 1, nested within 165 
hospitals at level 2, to enable exploration of between-hospital variation in the performance of 
emergency cholecystectomy, the null random intercept model fitted with hospital-only effects 
generated estimates of a patient receiving an emergency cholecystectomy (Fig. 2). For 61 
hospitals (37.0 per cent), the 95 per cent confidence interval crossed the zero line, indicating 
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that the number of emergency cholecystectomies was not significantly different from 
average. In 46 hospitals (27.9 per cent), the 95 per cent confidence interval lay entirely above 
the zero line, suggesting that they performed a higher than average number of emergency 
cholecystectomies. In contrast, 15 hospitals (9.1 per cent) performed significantly lower 
numbers of emergency cholecystectomies than average.  There was strong evidence of 
interhospital variation for having an emergency cholecystectomy (likelihood ratio statistic 
848.4, P < 0.001). 
+B: Effect of co-variables on variation in emergency cholecystectomy rates 
The random intercept model was extended to include explanatory variables (Table S1, 
supporting information) producing a multilevel logistic random intercept model (Table 3). 
Increasing age, biliary colic, the need for further radiological imaging and interventions, 
endoscopic interventions and admission to a non-specialist HPB centre all significantly 
reduced the likelihood of an emergency cholecystectomy being performed. Hospital volume 
was not a significant factor. Following the inclusion of explanatory variables in the model, 
the estimated between-hospital variation decreased from 2.0 to 1.8, indicating that the 
distribution of the explanatory variables differed across hospitals. To determine how much 
variation between hospitals was explained by inclusion of the variables (age, sex, ASA, BMI, 
indication, ultrasound findings, MRCP, ERCP, specialist HPB centre and acute hospital 
status) within this model, the variance partition coefficient was calculated. Within the model, 
65 per cent of the variation was attributable to hospital characteristics. 
To show how much variation was seen for a given patient across the 165 hospitals, the 
random intercept model was used to calculate the probability of receiving an emergency 
cholecystectomy for a woman with: ASA grade I or II, BMI at least 25.0 kg/m2, acute 
cholecystitis, ultrasound imaging showing a thick-walled gallbladder and normal CBD, and 
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age 40 years or more (scenario 1) or less than 40 years (scenario 2). In addition, the 
probability of receiving an emergency cholecystectomy was predicted for three further 
examples: any patient aged 60 years or less with pancreatitis (scenario 3) or biliary colic 
requiring no further investigations (scenario 4) or requiring MRCP (scenario 5). Fig. 3 shows 
the predicted probability for a patient receiving an emergency cholecystectomy together with 
corresponding 95 per cent confidence intervals for the five scenarios. For scenario 1, the 
mean predicted probability of receiving an emergency cholecystectomy was 0.52 (95 per cent 
c.i. 0.45 to 0.57). The predicted probabilities, however, ranged from 0.02 to 0.95 across the 
165 hospitals, demonstrating significant between-hospital variation for this common clinical 
presentation. For the scenarios described, the need for further imaging and certain diagnoses 
seemed to reduce the probability of receiving an emergency cholecystectomy. 
+A: Discussion 
This population-based study, using prospectively collected data, with high rates of complete 
data, evaluated the practice of emergency cholecystectomy for acute gallbladder diseases. 
There was significant variation across UK and Irish hospitals, even when different 
gallbladder pathologies were considered. This was due to both patient (age, certain 
indications, need for further radiological imaging and interventions) and hospital (admission 
to a specialist HPB centre) factors. Patients with similar characteristics presenting to the 165 
hospitals studied did not receive similar care. 
Level 1 evidence supports emergency cholecystectomy for biliary colic, acute 
cholecystitis and gallstone pancreatitis, based on shortened total hospital stay, a similar 
conversion rate to open cholecystectomy and the elimination of recurrent gallstone 
symptoms, resulting in less time off work than with planned delayed cholecystectomy3–15,29. 
Although much of the supporting evidence comes from specialist institutions and enthusiasts, 
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population-level data suggest that emergency cholecystectomy may be associated with poorer 
patient outcomes2,30. The findings of the present population-based cohort study are consistent 
with those of other cohort studies demonstrating different practices and variations in 
emergency cholecystectomy across hospitals16–20. These earlier studies suggested that 
variations were related to age, patient co-morbidities, surgeons’ competing elective clinical 
obligations, comfort with emergency laparoscopy, the availability of hospital resources and 
insurance status31–33. 
 The present prospective study collected and independently validated data obtained 
from trainee-led networks in the UK and Ireland. This methodology is powerful when 
studying surgical variations34,35. Variations between hospitals in the performance of 
emergency cholecystectomy were analysed using multilevel, multivariable logistic regression 
modelling. This identified both patient and hospital variables accounting for the between-
hospital variation seen. The patient variables identified here (increasing age, co-morbidity 
and indication) seem predictable and have been noted previously21. The need for further 
radiological imaging and interventions, endoscopic interventions and hospital factors (such as 
admission to a specialist HPB centre) may in part be related to logistical barriers at certain 
institutions, and balanced against the pressures from other acute and elective procedures. 
Specialist HPB centres were associated with higher performance of emergency 
cholecystectomy. This may reflect a better understanding of the evidence comparing the 
outcomes of emergency and delayed cholecystectomy, or an enthusiasm to deliver an 
emergency cholecystectomy service. 
There are limitations to this study. The data represent a 2-month snapshot of practice 
and may account for why hospital volume was not found to be important in this analysis, 
compared with other reports which have relied mainly on administrative data sets that may be 
incomplete or inaccurate2,30. The extent of variation across hospitals in the present study was 
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large, although the model accounted for only 65 per cent of the variation seen, suggesting the 
presence of other variables not characterized in this study. This may reflect factors that alter 
surgical decision-making which are difficult to quantify, such as complexity of other 
emergency admissions and pressures on emergency operating time. However, many surgeon 
characteristics, such as consultant subspecialty, would be expected to overlap with the 
hospital characteristics included here.  
Initiatives targeting better delivery of all emergency surgical care, including a 
dedicated service for emergency surgery referrals, a surgeon-of-the-week practice model, 
operating room time during the day dedicated to emergency procedures, and 7-day working, 
have all been proposed as potential solutions36–39. For example, dedicated emergency surgery 
team and operating lists are believed to provide efficient management of patients with 
gallstone diseases40–42. In the present study, however, performance of emergency 
cholecystectomy was not improved with emergency gallbladder operating lists nor with 
increasing numbers of consultants who performed cholecystectomy. This again suggests that 
there are hospital-level barriers in the delivery of effective emergency cholecystectomy 
services.  
Similar variations in the performance of emergency cholecystectomy have been noted 
in other healthcare systems16–20. Although the present study analysed data from patients 
treated in UK and Irish hospitals, patient and hospital characteristics are likely to be similar 
across other European and high-income countries. Here, 46 hospitals provided higher rates of 
emergency cholecystectomy than others. A qualitative service evaluation of these hospitals 
and selected centres that perform high rates of emergency cholecystectomy across high-
income countries may provide a better understanding of the provision in these hospitals and 
provide a model for care.   
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Table 1 Patient factors in relation to performance of emergency and delayed cholecystectomy 
 Emergency 
cholecystectomy 
(n = 1451) Delayed cholecystectomy 
(n  = 3293) 
Age (years)   
< 40 441 (30.4) 859 (26.1) 
40–60 510 (35.1) 1161 (35.3) 
61–80 435 (30.0) 1108 (33.6) 
> 80 65 (4.5) 165 (5.0) 
Sex   
F 1000 (68.9) 2189 (66.5) 
M 451 (31.1) 1104 (33.5) 
BMI (kg/m2)   
< 17.9 6 (0.4) 17 (0.5) 
18.0–24.9 262 (18.1) 667 (20.3) 
25.0–29.9 494 (34.0) 1108 (33.6) 
30.0–34.9 337 (23.2) 805 (24.4) 
≥ 35.0 250 (17.2) 560 (17.0) 
Unknown 102 (7.0) 136 (4.1) 
ASA fitness grade   
I 516 (35.6) 1127 (34.2) 
II 704 (48.5) 1746 (53.0) 
III 204 (14.1) 387 (11.8) 
≥ IV  12 (0.8) 9 (0.3) 
Unknown 15 (1.0) 24 (0.7) 
Indication   
Biliary colic 295 (20.3) 955 (29.0) 
Acute cholecystitis 795 (54.8) 1369 (41.6) 
Pancreatitis 268 (18.5) 545 (16.6) 
CBD stone 83 (5.7) 386 (11.7) 
 28 
Polyp 2 (0.1) 16 (0.5) 
Dyskinesia 1 (0.1) 9 (0.3) 
Acalculous 6 (0.4) 11 (0.3) 
Other/missing 1 (0.1) 2 (0.1) 
Ultrasonography performed 1348 (92.9) 3163 (96.1) 
Ultrasound findings   
Thick-walled 729 (50.2) 1412 (42.9) 
CBD dilated 289 (19.9) 793 (24.1) 
CT performed 290 (20.0) 680 (20.6) 
MRCP performed 417 (28.7) 1319 (40.1) 
ERCP performed 139 (9.6) 670 (20.3) 
Values in parentheses are percentages. CBD, common bile duct; MRCP, magnetic retrograde 
cholangiopancreatography; ERCP, endoscopic retrograde cholangiopancreatography. 
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(n = 1451) 
Delayed 
cholecystectomy 
(n  = 3293) 
University hospital 764 (52.7) 1378 (41.8) 
Specialist HPB centre 510 (35.1) 705 (21.4) 
Acute hospital 1438 (99.1) 3071 (93.3) 
No. of consultants performing 
cholcystectomies* 
9 (4–8) 8 (3–4) 
Country   
England 1038 (71.5) 2696 (81.9) 
Northern Ireland 53 (3.7) 98 (3.0) 
Republic of Ireland 59 (4.1) 157 (4.8) 
Scotland 251 (17.3) 245 (7.4) 
Wales 50 (3.4) 97 (2.9) 
No. of hospital beds   
< 100 1 (0.1) 21 (0.6) 
101–500 442 (30.5) 1377 (41.8) 
501–1000 697 (48.0) 1579 (48.0) 
> 1000 311 (21.4) 316 (9.6) 
ERCP service 1382 (95.2) 3094 (94.0) 
Ease of performing IOC    
Not possible 22 (1.5) 121 (3.7) 
      With difficulty 212 (14.6) 722 (21.9) 
With ease 1217 (83.9) 2450 (74.4) 
Emergency gallbladder operating lists   
No 993 (68.4) 2225 (67.6) 
 30 
Ad hoc 152 (10.5) 403 (12.2) 
Once per week 162 (11.2) 212 (6.4) 
More than once per week 138 (9.5) 292 (8.9) 
Elective surgery only at hospital 6 (0.4) 161 (4.9) 
Consultant specialty   
Oesophagogastric 560 (38.6) 1220 (37.0) 
HPB 314 (21.6) 634 (19.3) 
Colorectal 352 (24.3) 831 (25.2) 
Breast 42 (2.9) 137 (4.2) 
Vascular 57 (3.9) 141 (4.3) 
Other 117 (8.1) 327 (9.9) 
Hospital volume   
High 549 (37.8) 969 (29.4) 
Medium 497 (34.3) 1141 (34.6) 
Low 405 (27.9) 1183 (35.9) 
 
Values in parentheses are percentages unless indicated otherwise; *values are median (i.q.r.). 




Table 3 Multilevel random intercept logistic regression of association between patient and 
hospital characteristics and receiving an emergency cholecystectomy 
 Odds ratio for emergency 
versus delayed 
cholecystectomy P 
Patient factors   
Age (years)   
< 40 1.00 (reference)  
40–60 0.68 (0.56, 0.84) < 0.001 
61–80 0.54 (0.42, 0.68) < 0.001 
> 80 0.48 (0.31, 0.74) 0.001 
Sex   
F 1.00 (reference)  
M 0.84 (0.70, 1.01) 0.058 
BMI (kg/m2)   
18.0–24.9 1.00 (reference)  
< 17.9 2.12 (0.78, 6.36) 0.179 
25.0–29.9 1.23 (0.98, 1.54) 0.069 
30.0–34.9 1.15 (0.91, 1.47) 0.247 
≥ 35.0 1.12 (0.85, 1.46) 0.411 
ASA fitness grade   
I 1.00 (reference)  
II 0.96 (0.79, 1.16) 0.670 
III 1.43 (1.07, 1.91) 0.016 
≥ IV 4.70 (1.45, 15.25) 0.010 
Indication   
Biliary colic 1.00 (reference)  
Acute cholecystitis 2.23 (1.77, 2.80) < 0.001 
Pancreatitis 2.39 (1.85, 3.10) < 0.001 
 32 
CBD stone 1.12 (0.76, 1.65) 0.570 
Gallbladder wall on ultrasonography   
Normal 1.00 (reference)  
Thickened 1.20 (0.99, 1.44) 0.057 
CBD diameter on ultrasonography   
Normal 1.00 (reference)  
Dilated 1.30 (1.04, 1.62) 0.019 
MRCP   
No 1.00 (reference)  
Yes 0.64 (0.53, 0.77) < 0.001 
ERCP   
No 1.00 (reference)  
Yes 0.49 (0.37, 0.65) < 0.001 
Hospital factors   
Specialist HPB centre   
No 1.00 (reference)  
Yes 2.67 (1.51, 4.71) 0.001 
Acute hospital   
No 1.00 (reference)  
Yes 12.61 (4.04, 39.35) < 0.001 
Values in parentheses are 95 per cent confidence intervals. CBD, common bile duct; MRCP, 
magnetic retrograde cholangiopancreatography; ERCP, endoscopic retrograde 
cholangiopancreatography; HPB, hepatopancreatobiliary. 
 
 
